跳至主要内容
临床试验/NCT00788463
NCT00788463已完成2 期

A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps

Lawson Health Research Institute1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2006年11月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
30
试验地点
1
主要终点
Difference in overall quality of life as measured by the Rhinitis Quality of Life Questionnaire

研究概览

简要总结

The purpose of this study is to determine if intranasal Beclomethasone delivered by aerosol or spray is more effective in treatment of nasal polyps.

详细描述

Aqueous and aerosol delivery of intranasal corticosteroids has never been directly compared previously in patients with nasal polyps and it is unknown whether one is superior.

This objective of this study is to compare the efficacy of intranasal beclomethasone by two different delivery systems, aerosol and aqueous spray in patients with nasal polyps. Primary endpoint is the difference in the overall quality of life as measured by the Rhinitis Quality of Life Questionnaire. The secondary endpoint is the change in Nasal Airflow Resistance as measured by rhinomanometry.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years old
  • New diagnosis of nasal polyps confirmed by two physicians

排除标准

  • Intranasal corticosteroid use within 4 weeks
  • Oral corticosteroids use within 4 weeks
  • Oral corticosteroid inhalation (ie for treatment of asthma or COPD) of Budesonide >400ug daily, Fluticasone >250ug daily, Beclomethasone >400ug daily
  • Contraindication to intranasal corticosteroid
  • Inability to give informed consent
  • Participation in another clinical trial
  • Pregnancy (or not using effective method of contraception) or lactation
  • Cystic fibrosis

研究组 & 干预措施

Aerosol

Experimental

干预措施: Intranasal Beclomethasone aerosol (Drug)

Spray

Active Comparator

干预措施: Intranasal Beclomethasone spray (Drug)

结局指标

主要结局

Difference in overall quality of life as measured by the Rhinitis Quality of Life Questionnaire

时间窗: 0, 1, 3, 6 months

次要结局

  • Difference in Nasal Airflow Resistance as measured an anterior rhinomanometry(0, 1, 3, 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验